Based on our series of in vitro studies with human and mouse melanoma cells and in vivo study with syngeneic melanoma mouse models of GH excess, here, we hypothesized that a GHR antagonist (GHRA) might successfully suppress melanoma tumor growth in vivo. The gene discussed is GH1; the disease is neoplasm.